Lynn Mack is an Endocrinology/Metabolic physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 19 publications with 467 citations (h-index 9); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp
Sponsor: University of Nebraska
- Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
Sponsor: University of Nebraska
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
46.8%Insulin Analog18.5%Novolog Flexpen31%Basaglar Kwikpen U-10018%Lantus Solostar15%Humalog10%Humalog Kwikpen U-10010%Novolog10%Levemir Flexpen6%Part D<11 patientsGLP-1 receptor agonist10.6%Mounjaro35%Ozempic30%Trulicity19%Rybelsus16%Part D<11 patients+ 5 more classes in this area
Hormonal (systemic)
32.8%l-Thyroxine26.9%Levothyroxine Sodium79%Synthroid21%Part D≥60 patientsVasopressin Analog1.3%Desmopressin Acetate100%Part D<11 patients+ 4 more classes in this area
Cardiovascular
12.5%Statin10.1%Rosuvastatin Calcium53%Atorvastatin Calcium36%Pravastatin Sodium11%Part D<11 patientsAngiotensin receptor blocker (ARB)1.3%Losartan Potassium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
James Armitage, MD
University of Nebraska Medical Center
Julie Vose, MD
University of Nebraska Medical Center
Kathleen Moore, MD
University of Nebraska Medical Center
Ted Mikuls, MD
University of Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”